Invitation to Etteplan Oyj's Annual General Meeting of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Invitation to Etteplan Oyj's Annual General Meeting of Shareholders

ETTEPLAN OYJ, STOCK EXCHANGE RELEASE, FEBRUARY 11, 2015, AT 2.30 P.M.


INVITATION TO ETTEPLAN OYJ’S ANNUAL GENERAL MEETING OF SHAREHOLDERS

The shareholders of Etteplan Oyj (“Company”) are invited to the Annual General Meeting of Shareholders. The Meeting will be held on Friday, March 27, 2015 starting at 1:00 p.m. at the premises of the Company at the address Ensimmäinen Savu, 01510 Vantaa, Finland. The reception of the persons who have registered in for the Meeting will commence at 12:30 p.m.

A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING:

1. Opening of the Meeting

2. Calling the Meeting to order

3. Election of person to scrutinize the minutes and to supervise the counting of votes

4. Recording the legality of the Meeting

5. Recording the attendance at the Meeting and adoption of the list of votes

6. Presentation of the financial statements for 2014, including consolidated financial statements, and Annual Report

  • Review by the President and CEO

7. Presentation of the Auditor’s report

8. Adoption of the financial statements and consolidated financial statements

9. Resolution on the use of the profit shown on the balance sheet and the payment of the dividend

The Board proposes to the Annual General Meeting that a dividend of EUR 0.15 per share would be paid for the financial year 2014. The dividend will be paid to the shareholders registered on the record date in the shareholders' register maintained by Euroclear Finland Ltd (formerly Finnish Central Securities Depository Ltd). The record date of the payment of dividend would be March 31, 2015. The dividend is proposed to be paid on April 9, 2015.

10. Resolution on the discharge of the members of the Board of Directors as well as the President and CEO from liability

11. Resolution on the number of members of the Board of Directors as well as resolution on the remuneration of the members of the Board of Directors and the Auditor

The Nomination and Remuneration Committee of the Board of Directors proposes to the Annual General Meeting that the Board of Directors would consist of six members.

The Nomination and Remuneration Committee of the Board of Directors proposes that the remuneration of the Board of Directors would be EUR 24,400 per year for each member of the Board and EUR 48,800 per year for the Chairman.

The Nomination and Remuneration Committee of the Board of Directors also proposes that the Annual General Meeting would resolve on the remuneration of the Board of Directors and its Nomination and Remuneration Committee per meeting as follows:

The Board of Directors

Chairman            EUR 1,200 per meeting

Members             EUR 600 per meeting

Nomination and Remuneration Committee

Chairman            EUR 1,200 per meeting

Members             EUR 600 per meeting

The Nomination and Remuneration Committee of the Board of Directors proposes that the Auditor be paid a fee according to invoice approved by the Company.

12. Election of the Board of Directors

The Nomination and Remuneration Committee of the Board of Directors proposes that the Annual General Meeting would re-elect Robert Ingman, Patrick von Essen, Pertti Nupponen, Teuvo Rintamäki and Leena Saarinen to the Board of Directors and elect Matti Huttunen as a new member to the Board of Directors. All proposed members have given their consent to the election. More information on the proposed members is available on Etteplan Oyj's website at www.etteplan.com.

The shareholder representing 66 percent of the Company’s shares and voting rights has announced to support the proposal.

13. Election of the Auditor

The Board proposes that two auditors would be elected for the Company. The Board proposes that Authorized Public Accounting Firm PricewaterhouseCoopers Oy, with Authorized Public Accountant Mr. Kaj Wasenius as the main responsible auditor, be elected as the Company’s Auditor. In addition, the Board proposes that Certified Auditor Olli Wesamaa be elected as the Company’s second Auditor.

14. Authorizing the Board of Directors to resolve on the repurchase of the Company's own shares

The Board proposes that the Annual General Meeting authorize the Board of Directors to resolve on the repurchase of the Company’s own shares in one or more tranches using the Company’s unrestricted equity. A maximum of 2,000,000 shares in the Company may be repurchased. The Company may deviate from the obligation to repurchase shares in proportion to the shareholders' current holdings, i.e., the Board has the right to decide on a directed repurchase of the Company’s own shares.

The authorization includes the right for the Board to resolve on the repurchase of the Company’s own shares through a tender offer made to all shareholders on equal terms and conditions and at the price determined by the Board, or in public trading organized by the NASDAQ OMX Helsinki Ltd at the market price valid at any given time, so that the Company’s total holding of own shares does not exceed ten (10) per cent of all the shares in the Company. The minimum price for the shares to be repurchased is the lowest market price quoted for the shares in the Company in public trading and, correspondingly, the maximum price is the highest market price quoted for the shares in the Company in public trading during the validity of the authorization.

Should the shares in the Company be repurchased in public trading, such shares will not be purchased in proportion to the shareholders’ current holdings. In that case there must be a weighty financial reason for the Company to repurchase its own shares. The shares may be repurchased in order to be used as consideration in potential acquisitions or in other structural arrangements. The shares may as well be used for carrying out Company's incentive schemes for its personnel. The repurchased shares may be retained by the Company, invalidated or transferred further.

The repurchase of the Company's own shares will reduce the non-restricted equity of the Company.

The authorization is valid for 18 months from the date of the resolution of the Annual General Meeting starting on March 27, 2015 and ending on September 26, 2016. The authorization will replace the corresponding previous authorization.

15. Closing of the Meeting

B. DOCUMENTS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

The proposals for the decisions on the matters on the agenda of the Annual General Meeting as well as this invitation are available on Etteplan Oyj's website at www.etteplan.com. Etteplan Oyj’s annual report, which includes the Company's financial statements as well as the Board of Directors’ and Auditor's reports, is available on the above-mentioned website no later than on March 6, 2015. Copies of the documents will be sent to shareholders upon request and will also be available at the Annual General Meeting. The minutes of the Annual General Meeting will be available on the above-mentioned website as from April 10, 2015 at the latest.

C. INSTRUCTIONS FOR THE PARTICIPANTS IN THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

Shareholders registered in the shareholders’ register

A shareholder who on March 17, 2015, is registered as a shareholder in the Company’s shareholder register maintained by Euroclear Finland Ltd (Finnish Central Securities Depository Ltd) is entitled to participate in the Annual General Meeting.

A shareholder who wishes to participate in the Annual General Meeting must notify the Company of his/her intention to do so by March 24, 2015 at 12 p.m. Finnish time either by mail to Etteplan Oyj, Annual General Meeting, Muovitie 1, 15860 Hollola, Finland, by telephone to +358 10 307 2006 or by e-mail to registration@etteplan.com.

Written notifications to participate in the Meeting must have arrived to the Company prior to the expiry of the registration period.

In connection with the registration, a shareholder shall notify his/her name, personal identification number or business ID, address, telephone number and the name of a possible assistant or proxy representative and the personal identification number of a proxy representative. The personal data given to Etteplan Oyj is used only in connection with the Annual General Meeting and with the processing of related registrations.

Holders of nominee registered shares

A holder of nominee registered shares has the right to participate in the Annual General Meeting by virtue of such shares, based on which he/she on the record date of the Annual General Meeting, i.e. on March 17, 2015, would be entitled to be registered in the shareholders’ register of the Company held by Euroclear Finland Ltd. The right to participate in the Annual General Meeting requires, in addition, that the shareholder on the basis of such shares has been registered into the temporary shareholders’ register held by Euroclear Finland Ltd at the latest by March 24, 2015 at 10 am. As regards nominee registered shares this constitutes due registration for the Annual General Meeting.

Holders of nominee registered shares are advised to request the necessary instructions regarding the registration in the temporary shareholder’s register of the Company, the issuing of proxy documents and registration for the Annual General Meeting from their custodian bank.

The account management organization of the custodian bank shall register a holder of nominee registered shares, who wants to participate in the Annual General Meeting, into the temporary shareholders' register of the Company at the latest on March 24, 2015 at 10.00 a.m.

Proxy representative and powers of attorney

Shareholders may participate in the Annual General Meeting and exercise their rights at the Meeting by way of proxy representation. Proxy representatives shall produce a dated letter of proxy or otherwise in a reliable manner demonstrate their right to represent the shareholder at the Meeting.

Any proxy documents, identified and dated, should be delivered to the Company for inspection to the address mentioned above before the deadline for the registration.

When a shareholder participates in the Annual General Meeting by means of several proxy representatives representing the shareholder with shares at different securities accounts, the shares by which each proxy representative represents the shareholder shall be identified in connection with the registration for the Annual General Meeting.

Other instructions and information

Pursuant to Chapter 5, Section 25 of the Companies’ Act, a shareholder who is present at the Annual General Meeting has the right to request information with respect to the matters to be considered at the Meeting.

On the date of this invitation, February 11, 2015, the total number of shares in Etteplan Oyj and votes represented by such shares is 20 179 414, of which 308,886 are shares held by the Company. The shares held by the Company do not have voting rights.

Vantaa, February 11, 2015

Etteplan Oyj

Board of Directors


Additional information:
Juha Näkki, President and CEO, tel. +358 400 606 372


DISTRIBUTION:
NASDAQ OMX Helsinki
Major media

www.etteplan.com


Etteplan provides engineering services and technical documentation solutions to the world's leading companies in the manufacturing industry. Our services are geared to improve the competitiveness of our customers' products and engineering processes throughout the product life cycle. The results of Etteplan's innovative engineering can be seen in numerous industrial solutions and everyday products.

In 2014, Etteplan had a turnover of EUR 131.9 million. The company has more than 1,800 professionals in Finland, Sweden, the Netherlands and China. Etteplan's shares are listed on NASDAQ OMX Helsinki Ltd under the ticker ETT1V.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 2

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 1

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 2

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 2

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 3

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 3

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 5

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 2

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 2

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading

Top 5 Most Recently Viewed Articles

Virbac Sees Revenue Surge in the First Half of 2025

Updated Category News Views 243

Virbac's Impressive Growth in Early 2025 In an exciting development for Virbac, the company has announced a remarkable revenue growth of +5.6% for the first half of 2025, adjusted for constant exchange rates and considering its consolidation scope. This growth speaks volumes about the ability of Virbac to adapt and thrive in a competitive animal health market. Key...

Continue Reading
Amprius Technologies Delivers Cutting-Edge EV Cells to Industry

Updated Category News Views 54

Amprius Technologies Ships Advanced EV Cells Amprius Technologies, Inc. (NYSE: AMPX), a pioneer in high-performance lithium-ion batteries, has made a significant advancement by delivering its SiMaxx™ A-Sample EV Cells to a prominent consortium that focuses on developing cutting-edge battery technologies. This collaboration aims to address crucial performance and cost...

Continue Reading
Jyske Bank Successfully Completes Bond Offering with Confidence

Updated Category News Views 268

Jyske Bank A/S Completes Significant Bond Offering Jyske Bank A/S has successfully concluded a substantial bond offering, demonstrating confidence in its financial health and the stability of the market. This bond issuance, involving a total of 750 million euros, was categorized as a EUR 6.25NC5.25 Reg S Eurobond. Notably, it has been officially listed on the Dublin stock...

Continue Reading
Nitrado Emerges as the Premier Game Server Hosting Solution

Updated Category News Views 296

Nitrado's Rise in Game Server Hosting Nitrado has gained significant recognition in recent times as a provider of game server hosting, particularly in its ability to cater to a variety of online multiplayer games. As renovations within the gaming industry continue, the need for dependable hosting solutions has escalated. Players want uninterrupted gameplay, enhanced...

Continue Reading
Windtree Therapeutics Gains Key Approvals and Financial Backing

Updated Category News Views 154

Windtree Therapeutics Inc. Celebrates Stockholder Approvals Windtree Therapeutics Inc. (NASDAQ: WINT), a notable biotechnology company focused on innovative biological solutions, is excited to share the successful outcomes from its Annual Meeting of Stockholders. This important meeting, which took place online, showcased the commitment and support of its dedicated...

Continue Reading